|

SEphB4-HSA Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: sB4HSA

Pipeline

Phase 2/3: 1

Top Sponsors

  • Vasgene Therapeutics, Inc1

Indications

  • Muscle-Invasive Bladder Carcinoma1
  • Metastatic Urothelial Carcinoma1
  • Cancer1

Santa Monica, California1 trial

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Sarcoma Oncology Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.